Search Results - "Bergenstal, Richard"

Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers by Bergenstal, Richard M

“…There is no argument that improving mean levels of glycemic control as judged by assays for glycated hemoglobin (HbA(1c)) reduces the risks of microvascular…”
Get full text

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials by Beck, Roy W, Bergenstal, Richard M, Riddlesworth, Tonya D, Kollman, Craig, Li, Zhaomian, Brown, Adam S, Close, Kelly L

“…This study evaluated the association of time in range (TIR) of 70-180 mg/dL (3.9-10 mmol/L) with the development or progression of retinopathy and development…”
Get full text

Continuous glucose monitoring: transforming diabetes management step by step by Bergenstal, Richard M

Get full text

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes by Inzucchi, Silvio E, Bergenstal, Richard M, Buse, John B, Diamant, Michaela, Ferrannini, Ele, Nauck, Michael, Peters, Anne L, Tsapas, Apostolos, Wender, Richard, Matthews, David R

“…In 2012, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a position statement on the management…”
Get full text

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia by Bergenstal, Richard M, Klonoff, David C, Garg, Satish K, Bode, Bruce W, Meredith, Melissa, Slover, Robert H, Ahmann, Andrew J, Welsh, John B, Lee, Scott W, Kaufman, Francine R

“…In this study involving patients with type 1 diabetes, sensor-augmented insulin-pump therapy plus automated insulin suspension when glucose dropped below 70 mg…”
Get full text

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes by Marso, Steven P, Daniels, Gilbert H, Brown-Frandsen, Kirstine, Kristensen, Peter, Mann, Johannes F.E, Nauck, Michael A, Nissen, Steven E, Pocock, Stuart, Poulter, Neil R, Ravn, Lasse S, Steinberg, William M, Stockner, Mette, Zinman, Bernard, Bergenstal, Richard M, Buse, John B

“…Patients with type 2 diabetes and high cardiovascular risk were assigned to receive either the glucagon-like peptide 1 analogue liraglutide or placebo. The…”
Get full text

Advances in technology for management of type 1 diabetes by Beck, Roy W, Bergenstal, Richard M, Laffel, Lori M, Pickup, John C

“…Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1…”
Get full text

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range by Battelino, Tadej, Danne, Thomas, Bergenstal, Richard M, Amiel, Stephanie A, Beck, Roy, Biester, Torben, Bosi, Emanuele, Buckingham, Bruce A, Cefalu, William T, Close, Kelly L, Cobelli, Claudio, Dassau, Eyal, DeVries, J Hans, Donaghue, Kim C, Dovc, Klemen, Doyle, 3rd, Francis J, Garg, Satish, Grunberger, George, Heller, Simon, Heinemann, Lutz, Hirsch, Irl B, Hovorka, Roman, Jia, Weiping, Kordonouri, Olga, Kovatchev, Boris, Kowalski, Aaron, Laffel, Lori, Levine, Brian, Mayorov, Alexander, Mathieu, Chantal, Murphy, Helen R, Nimri, Revital, Nørgaard, Kirsten, Parkin, Christopher G, Renard, Eric, Rodbard, David, Saboo, Banshi, Schatz, Desmond, Stoner, Keaton, Urakami, Tatsuiko, Weinzimer, Stuart A, Phillip, Moshe

“…Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring…”
Get full text

Continuous Glucose Monitoring-Derived Data Report-Simply a Better Management Tool by Battelino, Tadej, Bergenstal, Richard M

Get full text

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry by Miller, Kellee M, Foster, Nicole C, Beck, Roy W, Bergenstal, Richard M, DuBose, Stephanie N, DiMeglio, Linda A, Maahs, David M, Tamborlane, William V

“…To examine the overall state of metabolic control and current use of advanced diabetes technologies in the U.S., we report recent data collected on individuals…”
Get full text

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c by Beck, Roy W., Bergenstal, Richard M., Cheng, Peiyao, Kollman, Craig, Carlson, Anders L., Johnson, Mary L., Rodbard, David

“…Background: As the use of continuous glucose monitoring (CGM) increases, there is a need to better understand key metrics of time in range 70-180 mg/dL…”
Get full text

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring by Bergenstal, Richard M, Beck, Roy W, Close, Kelly L, Grunberger, George, Sacks, David B, Kowalski, Aaron, Brown, Adam S, Heinemann, Lutz, Aleppo, Grazia, Ryan, Donna B, Riddlesworth, Tonya D, Cefalu, William T

“…While A1C is well established as an important risk marker for diabetes complications, with the increasing use of continuous glucose monitoring (CGM) to help…”
Get full text

International Consensus on Use of Continuous Glucose Monitoring by Danne, Thomas, Nimri, Revital, Battelino, Tadej, Bergenstal, Richard M, Close, Kelly L, DeVries, J Hans, Garg, Satish, Heinemann, Lutz, Hirsch, Irl, Amiel, Stephanie A, Beck, Roy, Bosi, Emanuele, Buckingham, Bruce, Cobelli, Claudio, Dassau, Eyal, Doyle, 3rd, Francis J, Heller, Simon, Hovorka, Roman, Jia, Weiping, Jones, Tim, Kordonouri, Olga, Kovatchev, Boris, Kowalski, Aaron, Laffel, Lori, Maahs, David, Murphy, Helen R, Nørgaard, Kirsten, Parkin, Christopher G, Renard, Eric, Saboo, Banshi, Scharf, Mauro, Tamborlane, William V, Weinzimer, Stuart A, Phillip, Moshe

“…Measurement of glycated hemoglobin (HbA ) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday…”
Get full text

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes by Bergenstal, Richard M, Garg, Satish, Weinzimer, Stuart A, Buckingham, Bruce A, Bode, Bruce W, Tamborlane, William V, Kaufman, Francine R

Get full text

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group by Fleming, G Alexander, Petrie, John R, Bergenstal, Richard M, Holl, Reinhard W, Peters, Anne L, Heinemann, Lutz

“…Digital health technology, especially digital and health applications ("apps"), have been developing rapidly to help people manage their diabetes. Numerous…”
Get full text

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading by Beck, Roy W., Connor, Crystal G., Mullen, Deborah M., Wesley, David M., Bergenstal, Richard M.

“…HbA1c is a valuable metric for comparing treatment groups in a randomized trial, for assessing glycemic trends in a population over time, or for…”
Get full text

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes by Inzucchi, Silvio E., Bergenstal, Richard M., Buse, John B., Diamant, Michaela, Ferrannini, Ele, Nauck, Michael, Peters, Anne L., Tsapas, Apostolos, Wender, Richard, Matthews, David R.

Get full text

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial by Aroda, Vanita R, Rosenstock, Julio, Wysham, Carol, Unger, Jeffrey, Bellido, Diego, González-Gálvez, Guillermo, Takami, Akane, Guo, Hailing, Niemoeller, Elisabeth, Souhami, Elisabeth, Bergenstal, Richard M

“…This study was conducted to demonstrate the efficacy and safety of LixiLan (iGlarLixi), a novel, titratable, fixed-ratio combination of insulin glargine…”
Get full text

Trends in Insulin Use and Diabetes Control in the U.S.: 1988-1994 and 1999-2012 by Selvin, Elizabeth, Parrinello, Christina M, Daya, Natalie, Bergenstal, Richard M

Get full text

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group by Fleming, G. Alexander, Petrie, John R., Bergenstal, Richard M., Holl, Reinhard W., Peters, Anne L., Heinemann, Lutz

“…Digital health technology, especially digital and health applications (‘apps’), have been developing rapidly to help people manage their diabetes. Numerous…”
Get full text